Literature DB >> 23687522

Application of Immunohistochemistry and Molecular Diagnostics to Clinically Relevant Problems in Endometrial Cancer Bojana Djordjevic, Shannon Westin, Russell R. Broaddus.

Bojana Djordjevic1, Shannon Westin, Russell R Broaddus.   

Abstract

A number of different clinical scenarios are presented in which lab-based analyses beyond the usual diagnosis based on light microscopic examination of H&E stained slides - immunohistochemistry and PCR-based assays such as sequencing, mutation testing, microsatellite instability analysis, and determination of MLH1 methylation - are most helpful for guiding diagnosis and treatment of endometrial cancer. The central goal of this information is to provide a practical guide of key current and emerging issues in diagnostic endometrial cancer pathology that require the use of ancillary laboratory techniques, such as immunohistochemistry and molecular testing. The authors present the common diagnostic problems in endometrial carcinoma pathology, types of endometrial carcinoma, description of tissue testing and markers, pathological features, and targeted therapy.

Entities:  

Keywords:  Lynch Syndrome; endometrial cancer; targeted therapy

Year:  2012        PMID: 23687522      PMCID: PMC3653323          DOI: 10.1016/j.path.2012.08.004

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  108 in total

Review 1.  Fertility-sparing therapy for young women with endometrial cancer.

Authors:  Michael Frumovitz; David M Gershenson
Journal:  Expert Rev Anticancer Ther       Date:  2006-01       Impact factor: 4.512

2.  A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma.

Authors:  Brian M Slomovitz; Karen H Lu; Taren Johnston; Robert L Coleman; Mark Munsell; Russell R Broaddus; Cheryl Walker; Lois M Ramondetta; Thomas W Burke; David M Gershenson; Judith Wolf
Journal:  Cancer       Date:  2010-08-02       Impact factor: 6.860

3.  Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.

Authors:  Heather Hampel; Wendy Frankel; Jenny Panescu; Janet Lockman; Kaisa Sotamaa; Daniel Fix; Ilene Comeras; Jennifer La Jeunesse; Hidewaki Nakagawa; Judith A Westman; Thomas W Prior; Mark Clendenning; Pamela Penzone; Janet Lombardi; Patti Dunn; David E Cohn; Larry Copeland; Lynne Eaton; Jeffrey Fowler; George Lewandowski; Luis Vaccarello; Jeffrey Bell; Gary Reid; Albert de la Chapelle
Journal:  Cancer Res       Date:  2006-08-01       Impact factor: 12.701

4.  Testing women with endometrial cancer to detect Lynch syndrome.

Authors:  Janice S Kwon; Jenna L Scott; C Blake Gilks; Molly S Daniels; Charlotte C Sun; Karen H Lu
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

5.  PTEN/MMAC1 mutations in endometrial cancers.

Authors:  J I Risinger; A K Hayes; A Berchuck; J C Barrett
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

6.  PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformation.

Authors:  Katsutoshi Oda; Jennifer Okada; Luika Timmerman; Pablo Rodriguez-Viciana; David Stokoe; Keiko Shoji; Yuji Taketani; Hiroyuki Kuramoto; Zachary A Knight; Kevan M Shokat; Frank McCormick
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

7.  Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.

Authors:  Anna Yemelyanova; Hongxiu Ji; Ie-Ming Shih; Tian-Li Wang; Lee-Shu-Fune Wu; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2009-10       Impact factor: 6.394

8.  Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability.

Authors:  Shannon A Kuismanen; Anu-Liisa Moisio; Pascal Schweizer; Kaspar Truninger; Reijo Salovaara; Johanna Arola; Ralf Butzow; Josef Jiricny; Minna Nyström-Lahti; Päivi Peltomäki
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

9.  K-ras activation in premalignant and malignant epithelial lesions of the human uterus.

Authors:  T Enomoto; M Inoue; A O Perantoni; G S Buzard; H Miki; O Tanizawa; J M Rice
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

10.  Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint.

Authors:  Seiryu Kamoi; Muna I AlJuboury; Marie-Rose Akin; Steven G Silverberg
Journal:  Int J Gynecol Pathol       Date:  2002-07       Impact factor: 2.762

View more
  2 in total

1.  Review of immunohistochemical typing of endometrial carcinoma at the Lagos University Teaching Hospital.

Authors:  Olayemi Olubunmi Dawodu; Kehinde Sharafadeen Okunade; Adetola Daramola; Adekunbiola Aina Fehintola Banjo
Journal:  Afr Health Sci       Date:  2019-09       Impact factor: 0.927

2.  Hospital-based study of epithelial malignancies of endometrial cancer frequency in lahore, pakistan, and common diagnostic pitfalls.

Authors:  Imrana Tanvir; Sabiha Riaz; Afshan Hussain; Riffat Mehboob; M Usman Shams; Haseeb Ahmad Khan
Journal:  Patholog Res Int       Date:  2014-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.